TreeWAS – Variant ID: rs12670403

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
N95.0 Postmenopausal bleeding	0.000	0.897	0.103
B37.8 Candidiasis of other sites	0.090	0.910	0.000
B37 Candidiasis	0.057	0.943	0.000
B37.4 Candidiasis of other urogenital sites	0.048	0.951	0.000
B37.7 Candidal septicaemia	0.046	0.954	0.000
B37.0 Candidal stomatitis	0.045	0.955	0.000
B37.2 Candidiasis of skin and nail	0.044	0.956	0.000
B37.3 Candidiasis of vulva and vagina	0.042	0.958	0.000
B37.6 Candidal endocarditis	0.041	0.959	0.000
B37.5 Candidal meningitis	0.041	0.959	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.041	0.959	0.000
B37.1 Pulmonary candidiasis	0.040	0.960	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.039	0.961	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.039	0.961	0.000
T45.0 Antiallergic and antiemetic drugs	0.038	0.962	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.037	0.962	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.037	0.963	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.036	0.964	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.036	0.964	0.000
T42.4 Benzodiazepines	0.033	0.967	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.033	0.967	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.032	0.967	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.032	0.968	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.032	0.968	0.000
T40.6 Other and unspecified narcotics	0.032	0.968	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.032	0.968	0.000
T46.1 Calcium-channel blockers	0.031	0.969	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.031	0.969	0.000
C15 Malignant neoplasm of oesophagus	0.031	0.969	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.031	0.969	0.000
T40.2 Other opioids	0.031	0.969	0.000
C15.9 Oesophagus, unspecified	0.030	0.970	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.030	0.970	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.030	0.970	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.030	0.970	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.029	0.970	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.030	0.970	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.029	0.971	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.029	0.971	0.000
C15.4 Middle third of oesophagus	0.029	0.971	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.029	0.971	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.029	0.971	0.000
C19 Malignant neoplasm of rectosigmoid junction	0.029	0.971	0.000
T40.5 Cocaine	0.028	0.972	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.028	0.972	0.000
T46.7 Peripheral vasodilators	0.028	0.972	0.000
C15-C26 Malignant neoplasms of digestive organs	0.028	0.972	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.028	0.972	0.000
T45.8 Other primarily systemic and haematological agents	0.028	0.972	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.028	0.972	0.000
T45.6 Fibrinolysis-affecting drugs	0.028	0.972	0.000
T45.4 Iron and its compounds	0.028	0.972	0.000
T45.3 Enzymes, not elsewhere classified	0.028	0.972	0.000
T50.1 Loop [high-ceiling] diuretics	0.028	0.972	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.028	0.972	0.000
T42.0 Hydantoin derivatives	0.028	0.972	0.000
T40.3 Methadone	0.028	0.972	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.028	0.972	0.000
T40.1 Heroin	0.027	0.972	0.000
C26 Malignant neoplasm of other and ill-defined digestive organs	0.028	0.972	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.027	0.973	0.000
B37.9 Candidiasis, unspecified	0.027	0.973	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.027	0.973	0.000
C18.9 Colon, unspecified	0.027	0.973	0.000
T50.7 Analeptics and opioid receptor antagonists	0.027	0.973	0.000
T50.5 Appetite depressants	0.027	0.973	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.027	0.973	0.000
T50.0 Mineralocorticoids and their antagonists	0.027	0.973	0.000
C18 Malignant neoplasm of colon	0.027	0.973	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.027	0.973	0.000
T40.8 Lysergide [LSD]	0.027	0.973	0.000
T40.7 Cannabis (derivatives)	0.027	0.973	0.000
T40.0 Opium	0.027	0.973	0.000
T42.3 Barbiturates	0.027	0.973	0.000
C26.0 Intestinal tract, part unspecified	0.027	0.973	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.026	0.974	0.000
C18.6 Descending colon	0.026	0.974	0.000
T50.4 Drugs affecting uric acid metabolism	0.026	0.974	0.000
T39.0 Salicylates	0.026	0.974	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.026	0.974	0.000
T42.2 Succinimides and oxazolidinediones	0.026	0.974	0.000
T40.4 Other synthetic narcotics	0.026	0.974	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.026	0.974	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.025	0.974	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.026	0.974	0.000
C15.0 Cervical part of oesophagus	0.025	0.975	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.025	0.975	0.000
T50.8 Diagnostic agents	0.025	0.975	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.025	0.975	0.000
T39.1 4-Aminophenol derivatives	0.025	0.975	0.000
T45.2 Vitamins, not elsewhere classified	0.024	0.975	0.000
T36 Poisoning by systemic antibiotics	0.024	0.975	0.000
T43.6 Psychostimulants with abuse potential	0.024	0.976	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.024	0.976	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.023	0.977	0.000
T43.9 Psychotropic drug, unspecified	0.023	0.977	0.000
T47.4 Other laxatives	0.023	0.977	0.000
T49.9 Topical agent, unspecified	0.023	0.977	0.000
T49.8 Other topical agents	0.023	0.977	0.000
T49.7 Dental drugs, topically applied	0.023	0.977	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.023	0.977	0.000
T49.5 Ophthalmological drugs and preparations	0.023	0.977	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.023	0.977	0.000
T49.3 Emollients, demulcents and protectants	0.023	0.977	0.000
T49.2 Local astringents and local detergents	0.023	0.977	0.000
T49.1 Antipruritics	0.023	0.977	0.000
C15.1 Thoracic part of oesophagus	0.023	0.977	0.000
C26.9 Ill-defined sites within the digestive system	0.023	0.977	0.000
C15.3 Upper third of oesophagus	0.023	0.977	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.023	0.977	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.022	0.977	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.022	0.977	0.000
T47.7 Emetics	0.022	0.977	0.000
T47.6 Antidiarrhoeal drugs	0.022	0.977	0.000
T47.5 Digestants	0.022	0.977	0.000
T47.3 Saline and osmotic laxatives	0.022	0.977	0.000
C15.8 Overlapping lesion of oesophagus	0.022	0.978	0.000
C15.2 Abdominal part of oesophagus	0.022	0.978	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.022	0.978	0.000
C17 Malignant neoplasm of small intestine	0.022	0.978	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.022	0.978	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.022	0.978	0.000
C25 Malignant neoplasm of pancreas	0.021	0.978	0.000
T41.5 Therapeutic gases	0.021	0.979	0.000
T41.4 Anaesthetic, unspecified	0.021	0.979	0.000
T41.3 Local anaesthetics	0.021	0.979	0.000
T41.2 Other and unspecified general anaesthetics	0.021	0.979	0.000
T41.1 Intravenous anaesthetics	0.021	0.979	0.000
T41.0 Inhaled anaesthetics	0.021	0.979	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.021	0.979	0.000
T38.9 Other and unspecified hormone antagonists	0.021	0.979	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.021	0.979	0.000
T38.7 Androgens and anabolic congeners	0.021	0.979	0.000
T38.5 Other oestrogens and progestogens	0.021	0.979	0.000
T38.4 Oral contraceptives	0.021	0.979	0.000
T38.2 Antithyroid drugs	0.021	0.979	0.000
T38.0 Glucocorticoids and synthetic analogues	0.021	0.979	0.000
T47.2 Stimulant laxatives	0.021	0.979	0.000
T47.0 Histamine H(2)-receptor antagonists	0.021	0.979	0.000
T45.5 Anticoagulants	0.021	0.979	0.000
C18.8 Overlapping lesion of colon	0.021	0.979	0.000
T39.4 Antirheumatics, not elsewhere classified	0.021	0.979	0.000
T39.2 Pyrazolone derivatives	0.021	0.979	0.000
T42.1 Iminostilbenes	0.021	0.979	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.021	0.979	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.021	0.979	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.021	0.979	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.021	0.979	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.021	0.979	0.000
T44.0 Anticholinesterase agents	0.021	0.979	0.000
T38.1 Thyroid hormones and substitutes	0.020	0.979	0.000
C15.5 Lower third of oesophagus	0.020	0.980	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.020	0.980	0.000
T48.4 Expectorants	0.020	0.980	0.000
T48.3 Antitussives	0.020	0.980	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.020	0.980	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.020	0.980	0.000
T48.0 Oxytocic drugs	0.020	0.980	0.000
C18.1 Appendix	0.020	0.980	0.000
C26.8 Overlapping lesion of digestive system	0.020	0.980	0.000
C26.1 Spleen	0.020	0.980	0.000
T48.5 Anti-common-cold drugs	0.020	0.980	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.020	0.980	0.000
T37.5 Antiviral drugs	0.020	0.980	0.000
T37.4 Anthelminthics	0.020	0.980	0.000
T37.3 Other antiprotozoal drugs	0.020	0.980	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.020	0.980	0.000
T37.1 Antimycobacterial drugs	0.020	0.980	0.000
T37.0 Sulphonamides	0.020	0.980	0.000
C18.4 Transverse colon	0.020	0.980	0.000
C24 Malignant neoplasm of other and unspecified parts of biliary tract	0.019	0.980	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.019	0.981	0.000
Z02.8 Other examinations for administrative purposes	0.019	0.981	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.019	0.981	0.000
C18.2 Ascending colon	0.019	0.981	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.018	0.981	0.000
C23 Malignant neoplasm of gallbladder	0.018	0.982	0.000
C25.9 Pancreas, unspecified	0.018	0.982	0.000
C17.0 Duodenum	0.018	0.982	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.018	0.982	0.000
T36.9 Systemic antibiotic, unspecified	0.018	0.982	0.000
T36.8 Other systemic antibiotics	0.018	0.982	0.000
T36.7 Antifungal antibiotics, systemically used	0.018	0.982	0.000
T36.6 Rifamycins	0.018	0.982	0.000
T36.5 Aminoglycosides	0.018	0.982	0.000
T36.4 Tetracyclines	0.018	0.982	0.000
T36.2 Chloramphenicol group	0.018	0.982	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.018	0.982	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.017	0.982	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.017	0.983	0.000
C25.3 Pancreatic duct	0.017	0.983	0.000
C17.1 Jejunum	0.017	0.983	0.000
C18.5 Splenic flexure	0.017	0.983	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.017	0.983	0.000
C25.7 Other parts of pancreas	0.017	0.983	0.000
C25.8 Overlapping lesion of pancreas	0.017	0.983	0.000
C22 Malignant neoplasm of liver and intrahepatic bile ducts	0.016	0.984	0.000
C17.8 Overlapping lesion of small intestine	0.016	0.984	0.000
C17.3 Meckel's diverticulum	0.016	0.984	0.000
T36.3 Macrolides	0.016	0.984	0.000
C21 Malignant neoplasm of anus and anal canal	0.016	0.984	0.000
C17.2 Ileum	0.016	0.984	0.000
C24.0 Extrahepatic bile duct	0.016	0.984	0.000
C18.7 Sigmoid colon	0.015	0.985	0.000
C25.4 Endocrine pancreas	0.015	0.985	0.000
T36.0 Penicillins	0.015	0.985	0.000
C25.0 Head of pancreas	0.015	0.985	0.000
C17.9 Small intestine, unspecified	0.014	0.986	0.000
C24.8 Overlapping lesion of biliary tract	0.014	0.986	0.000
C24.9 Biliary tract, unspecified	0.014	0.986	0.000
C21.8 Overlapping lesion of rectum, anus and anal canal	0.014	0.986	0.000
C18.0 Caecum	0.014	0.986	0.000
C22.1 Intrahepatic bile duct carcinoma	0.014	0.986	0.000
C25.2 Tail of pancreas	0.012	0.988	0.000
C22.7 Other specified carcinomas of liver	0.012	0.988	0.000
C22.4 Other sarcomas of liver	0.012	0.988	0.000
C22.3 Angiosarcoma of liver	0.012	0.988	0.000
C22.2 Hepatoblastoma	0.012	0.988	0.000
C18.3 Hepatic flexure	0.012	0.988	0.000
C25.1 Body of pancreas	0.012	0.988	0.000
C21.2 Cloacogenic zone	0.011	0.988	0.000
C24.1 Ampulla of Vater	0.011	0.988	0.000
T43.2 Other and unspecified antidepressants	0.011	0.989	0.000
R20.8 Other and unspecified disturbances of skin sensation	0.000	0.989	0.011
D07.5 Prostate	0.011	0.989	0.000
D07.1 Vulva	0.011	0.989	0.000
D07 Carcinoma in situ of other and unspecified genital organs	0.011	0.989	0.000
C20 Malignant neoplasm of rectum	0.010	0.990	0.000
C22.0 Liver cell carcinoma	0.010	0.990	0.000
D07.4 Penis	0.009	0.991	0.000
D07.2 Vagina	0.009	0.991	0.000
C21.1 Anal canal	0.008	0.992	0.000
R20 Disturbances of skin sensation	0.000	0.992	0.008
M94.86 Other specified disorders of cartilage (Lower leg)	0.000	0.992	0.008
R20.2 Paraesthesia of skin	0.000	0.992	0.008
B35-B49 Mycoses	0.008	0.992	0.000
Z02 Examination and encounter for administrative purposes	0.008	0.992	0.000
C16 Malignant neoplasm of stomach	0.008	0.992	0.000
D07.6 Other and unspecified male genital organs	0.008	0.992	0.000
D07.3 Other and unspecified female genital organs	0.008	0.992	0.000
D07.0 Endometrium	0.008	0.992	0.000
C22.9 Liver, unspecified	0.007	0.992	0.000
R20.3 Hyperaesthesia	0.000	0.992	0.008
M18.0 Primary arthrosis of first carpometacarpal joints, bilateral	0.000	0.993	0.007
M94.8 Other specified disorders of cartilage	0.000	0.993	0.007
C16.6 Greater curvature of stomach, unspecified	0.007	0.993	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.007	0.993	0.000
M94.89 Other specified disorders of cartilage (Site unspecified)	0.000	0.993	0.007
C16.4 Pylorus	0.006	0.993	0.000
B36 Other superficial mycoses	0.006	0.994	0.000
B48 Other mycoses, not elsewhere classified	0.006	0.994	0.000
B46 Zygomycosis	0.006	0.994	0.000
B45 Cryptococcosis	0.006	0.994	0.000
B43 Chromomycosis and phaeomycotic abscess	0.006	0.994	0.000
B42 Sporotrichosis	0.006	0.994	0.000
B41 Paracoccidioidomycosis	0.006	0.994	0.000
B40 Blastomycosis	0.006	0.994	0.000
B39 Histoplasmosis	0.006	0.994	0.000
B38 Coccidioidomycosis	0.006	0.994	0.000
Z02.9 Examination for administrative purposes, unspecified	0.006	0.994	0.000
Z02.7 Issue of medical certificate	0.006	0.994	0.000
Z02.6 Examination for insurance purposes	0.006	0.994	0.000
Z02.5 Examination for participation in sport	0.006	0.994	0.000
Z02.4 Examination for driving licence	0.006	0.994	0.000
Z02.3 Examination for recruitment to armed forces	0.006	0.994	0.000
Z02.2 Examination for admission to residential institution	0.006	0.994	0.000
Z02.1 Pre-employment examination	0.006	0.994	0.000
Z02.0 Examination for admission to educational institution	0.006	0.994	0.000
B47 Mycetoma	0.006	0.994	0.000
C16.5 Lesser curvature of stomach, unspecified	0.006	0.994	0.000
I72.4 Aneurysm of artery of lower extremity	0.006	0.994	0.000
M94.85 Other specified disorders of cartilage (Pelvic region and thigh)	0.000	0.994	0.006
R20.1 Hypoaesthesia of skin	0.000	0.994	0.006
C21.0 Anus, unspecified	0.005	0.995	0.001
C16.8 Overlapping lesion of stomach	0.005	0.995	0.000
C16.1 Fundus of stomach	0.005	0.995	0.000
K63.3 Ulcer of intestine	0.005	0.995	0.000
M94.84 Other specified disorders of cartilage (Hand)	0.000	0.995	0.005
M94.83 Other specified disorders of cartilage (Forearm)	0.000	0.995	0.005
M94.82 Other specified disorders of cartilage (Upper arm)	0.000	0.995	0.005
M94.81 Other specified disorders of cartilage (Shoulder region)	0.000	0.995	0.005
M94.80 Other specified disorders of cartilage (Multiple sites)	0.000	0.995	0.005
R20.0 Anaesthesia of skin	0.000	0.995	0.005
C16.3 Pyloric antrum	0.005	0.995	0.000
I31.9 Disease of pericardium, unspecified	0.005	0.995	0.000
T83.0 Mechanical complication of urinary (indwelling) catheter	0.005	0.995	0.000
C16.2 Body of stomach	0.005	0.995	0.000
C16.0 Cardia	0.005	0.995	0.000
B44 Aspergillosis	0.005	0.995	0.000
M94.88 Other specified disorders of cartilage (Other)	0.000	0.995	0.005
T78.4 Allergy, unspecified	0.005	0.995	0.000
B36.9 Superficial mycosis, unspecified	0.005	0.995	0.000
B49 Unspecified mycosis	0.005	0.995	0.000
B36.8 Other specified superficial mycoses	0.004	0.995	0.000
B36.3 Black piedra	0.004	0.995	0.000
B36.2 White piedra	0.004	0.995	0.000
B36.1 Tinea nigra	0.004	0.995	0.000
B36.0 Pityriasis versicolor	0.004	0.995	0.000
M34.9 Systemic sclerosis, unspecified	0.000	0.995	0.005
M94.87 Other specified disorders of cartilage (Ankle and foot)	0.000	0.995	0.004
B38.9 Coccidioidomycosis, unspecified	0.004	0.995	0.000
B38.8 Other forms of coccidioidomycosis	0.004	0.995	0.000
B38.7 Disseminated coccidioidomycosis	0.004	0.995	0.000
B38.4 Coccidioidomycosis meningitis	0.004	0.995	0.000
B38.3 Cutaneous coccidioidomycosis	0.004	0.995	0.000
B38.2 Pulmonary coccidioidomycosis, unspecified	0.004	0.995	0.000
B38.1 Chronic pulmonary coccidioidomycosis	0.004	0.995	0.000
B38.0 Acute pulmonary coccidioidomycosis	0.004	0.995	0.000
B39.9 Histoplasmosis, unspecified	0.004	0.995	0.000
B39.5 Histoplasmosis duboisii	0.004	0.995	0.000
B39.4 Histoplasmosis capsulati, unspecified	0.004	0.995	0.000
B39.3 Disseminated histoplasmosis capsulati	0.004	0.995	0.000
B39.2 Pulmonary histoplasmosis capsulati, unspecified	0.004	0.995	0.000
B39.1 Chronic pulmonary histoplasmosis capsulati	0.004	0.995	0.000
B39.0 Acute pulmonary histoplasmosis capsulati	0.004	0.995	0.000
B40.9 Blastomycosis, unspecified	0.004	0.995	0.000
B40.8 Other forms of blastomycosis	0.004	0.995	0.000
B40.7 Disseminated blastomycosis	0.004	0.995	0.000
B40.3 Cutaneous blastomycosis	0.004	0.995	0.000
B40.2 Pulmonary blastomycosis, unspecified	0.004	0.995	0.000
B40.1 Chronic pulmonary blastomycosis	0.004	0.995	0.000
B40.0 Acute pulmonary blastomycosis	0.004	0.995	0.000
B41.9 Paracoccidioidomycosis, unspecified	0.004	0.995	0.000
B41.8 Other forms of paracoccidioidomycosis	0.004	0.995	0.000
B41.7 Disseminated paracoccidioidomycosis	0.004	0.995	0.000
B41.0 Pulmonary paracoccidioidomycosis	0.004	0.995	0.000
B42.9 Sporotrichosis, unspecified	0.004	0.995	0.000
B42.8 Other forms of sporotrichosis	0.004	0.995	0.000
B42.7 Disseminated sporotrichosis	0.004	0.995	0.000
B42.1 Lymphocutaneous sporotrichosis	0.004	0.995	0.000
B42.0 Pulmonary sporotrichosis	0.004	0.995	0.000
B43.9 Chromomycosis, unspecified	0.004	0.995	0.000
B43.8 Other forms of chromomycosis	0.004	0.995	0.000
B43.2 Subcutaneous phaeomycotic abscess and cyst	0.004	0.995	0.000
B43.1 Phaeomycotic brain abscess	0.004	0.995	0.000
B43.0 Cutaneous chromomycosis	0.004	0.995	0.000
B45.9 Cryptococcosis, unspecified	0.004	0.995	0.000
B45.8 Other forms of cryptococcosis	0.004	0.995	0.000
B45.7 Disseminated cryptococcosis	0.004	0.995	0.000
B45.3 Osseous cryptococcosis	0.004	0.995	0.000
B45.2 Cutaneous cryptococcosis	0.004	0.995	0.000
B45.1 Cerebral cryptococcosis	0.004	0.995	0.000
B45.0 Pulmonary cryptococcosis	0.004	0.995	0.000
B46.9 Zygomycosis, unspecified	0.004	0.995	0.000
B46.8 Other zygomycoses	0.004	0.995	0.000
B46.5 Mucormycosis, unspecified	0.004	0.995	0.000
B46.4 Disseminated mucormycosis	0.004	0.995	0.000
B46.3 Cutaneous mucormycosis	0.004	0.995	0.000
B46.2 Gastro-intestinal mucormycosis	0.004	0.995	0.000
B46.1 Rhinocerebral mucormycosis	0.004	0.995	0.000
B46.0 Pulmonary mucormycosis	0.004	0.995	0.000
B48.8 Other specified mycoses	0.004	0.995	0.000
B48.7 Opportunistic mycoses	0.004	0.995	0.000
B48.4 Penicillosis	0.004	0.995	0.000
B48.3 Geotrichosis	0.004	0.995	0.000
B48.2 Allescheriasis	0.004	0.995	0.000
B48.1 Rhinosporidiosis	0.004	0.995	0.000
B48.0 Lobomycosis	0.004	0.995	0.000
B47.1 Actinomycetoma	0.004	0.995	0.000
B47.0 Eumycetoma	0.004	0.995	0.000
N95 Menopausal and other perimenopausal disorders	0.000	0.995	0.005
B47.9 Mycetoma, unspecified	0.004	0.995	0.000
C62.9 Testis, unspecified	0.004	0.996	0.000
M34.1 CR(E)ST syndrome	0.000	0.996	0.004
D05.7 Other carcinoma in situ of breast	0.004	0.996	0.000
M34 Systemic sclerosis	0.000	0.996	0.004
D03.3 Melanoma in situ of other and unspecified parts of face	0.004	0.996	0.000
R50.8 Other specified fever	0.004	0.996	0.000
M34.8 Other forms of systemic sclerosis	0.000	0.996	0.004
D00-D09 In situ neoplasms	0.004	0.996	0.000
D05 Carcinoma in situ of breast	0.004	0.996	0.000
Z22.3 Carrier of other specified bacterial diseases	0.000	0.996	0.004
B35 Dermatophytosis	0.004	0.996	0.000
D02 Carcinoma in situ of middle ear and respiratory system	0.004	0.996	0.000
B44.7 Disseminated aspergillosis	0.004	0.996	0.000
B44.2 Tonsillar aspergillosis	0.004	0.996	0.000
B44.0 Invasive pulmonary aspergillosis	0.004	0.996	0.000
K41.9 Unilateral or unspecified femoral hernia, without obstruction or gangrene	0.004	0.996	0.000
B44.8 Other forms of aspergillosis	0.004	0.996	0.000
D02.0 Larynx	0.004	0.996	0.000
M34.0 Progressive systemic sclerosis	0.000	0.996	0.004
D03 Melanoma in situ	0.004	0.996	0.000
I46.9 Cardiac arrest, unspecified	0.000	0.996	0.004
D05.0 Lobular carcinoma in situ	0.004	0.996	0.000
B44.1 Other pulmonary aspergillosis	0.003	0.996	0.000
M94 Other disorders of cartilage	0.000	0.996	0.004
D68.2 Hereditary deficiency of other clotting factors	0.000	0.997	0.003
I72 Other aneurysm	0.003	0.997	0.000
L27.0 Generalised skin eruption due to drugs and medicaments	0.003	0.997	0.000
K56.0 Paralytic ileus	0.000	0.997	0.003
M34.2 Systemic sclerosis induced by drugs and chemicals	0.000	0.997	0.003
N95.1 Menopausal and female climacteric states	0.000	0.997	0.003
N95.3 States associated with artificial menopause	0.000	0.997	0.003
W29.9 Unspecified place	0.000	0.997	0.003
B35.4 Tinea corporis	0.003	0.997	0.000
D03.8 Melanoma in situ of other sites	0.003	0.997	0.000
M21.16 Varus deformity, not elsewhere classified (Lower leg)	0.003	0.997	0.000
B35.9 Dermatophytosis, unspecified	0.003	0.997	0.000
T70.3 Caisson disease [decompression sickness]	0.003	0.997	0.000
D03.4 Melanoma in situ of scalp and neck	0.003	0.997	0.000
D05.9 Carcinoma in situ of breast, unspecified	0.003	0.997	0.000
B35.8 Other dermatophytoses	0.003	0.997	0.000
B35.5 Tinea imbricata	0.003	0.997	0.000
B35.2 Tinea manuum	0.003	0.997	0.000
B35.0 Tinea barbae and tinea capitis	0.003	0.997	0.000
D02.4 Respiratory system, unspecified	0.003	0.997	0.000
D02.3 Other parts of respiratory system	0.003	0.997	0.000
D02.1 Trachea	0.003	0.997	0.000
D01 Carcinoma in situ of other and unspecified digestive organs	0.003	0.997	0.000
M94.0 Chondrocostal junction syndrome [Tietze]	0.000	0.997	0.003
D09 Carcinoma in situ of other and unspecified sites	0.003	0.997	0.000
M62.89 Other specified disorders of muscle (Site unspecified)	0.000	0.997	0.003
D02.2 Bronchus and lung	0.003	0.997	0.000
N95.9 Menopausal and perimenopausal disorder, unspecified	0.000	0.997	0.003
Q85.8 Other phakomatoses, not elsewhere classified	0.003	0.997	0.000
D00 Carcinoma in situ of oral cavity, oesophagus and stomach	0.003	0.997	0.000
I72.3 Aneurysm of iliac artery	0.003	0.997	0.000
D03.9 Melanoma in situ, unspecified	0.003	0.997	0.000
D03.0 Melanoma in situ of lip	0.003	0.997	0.000
B44.9 Aspergillosis, unspecified	0.003	0.997	0.000
I72.9 Aneurysm of unspecified site	0.003	0.997	0.000
I72.8 Aneurysm of other specified arteries	0.003	0.997	0.000
Q85.9 Phakomatosis, unspecified	0.003	0.997	0.000
M94.3 Chondrolysis	0.000	0.997	0.003
M94.1 Relapsing polychondritis	0.000	0.997	0.003
Z22.1 Carrier of other intestinal infectious diseases	0.000	0.997	0.003
I72.1 Aneurysm of artery of upper extremity	0.003	0.997	0.000
I72.0 Aneurysm of carotid artery	0.003	0.997	0.000
K63.2 Fistula of intestine	0.003	0.997	0.000
D03.2 Melanoma in situ of ear and external auricular canal	0.003	0.997	0.000
I72.6 Aneurysm and dissection of vertebral artery	0.003	0.997	0.000
I72.5 Aneurysm and dissection of other precerebral arteries	0.003	0.997	0.000
R10.3 Pain localised to other parts of lower abdomen	0.003	0.997	0.000
D03.1 Melanoma in situ of eyelid, including canthus	0.003	0.997	0.000
M94.2 Chondromalacia	0.000	0.997	0.003
Q85 Phakomatoses, not elsewhere classified	0.003	0.997	0.000
D03.7 Melanoma in situ of lower limb, including hip	0.003	0.997	0.000
D68.0 Von Willebrand's disease	0.000	0.997	0.003
T70 Effects of air pressure and water pressure	0.003	0.997	0.000
T71 Asphyxiation	0.003	0.997	0.000
B35.1 Tinea unguium	0.002	0.997	0.000
M94.9 Disorder of cartilage, unspecified	0.000	0.997	0.003
Z99.8 Dependence on other enabling machines and devices	0.003	0.997	0.000
Z22 Carrier of infectious disease	0.000	0.997	0.003
M94.08 Chondrocostal junction syndrome [Tietze]-Other	0.000	0.997	0.002
I72.2 Aneurysm of renal artery	0.002	0.997	0.000
D68 Other coagulation defects	0.000	0.997	0.003
D09.9 Carcinoma in situ, unspecified	0.002	0.997	0.000
D09.7 Carcinoma in situ of other specified sites	0.002	0.997	0.000
Q85.0 Neurofibromatosis (nonmalignant)	0.002	0.997	0.000
T78 Adverse effects, not elsewhere classified	0.002	0.998	0.000
B35.6 Tinea cruris	0.002	0.998	0.000
D01.2 Rectum	0.002	0.998	0.000
D01.9 Digestive organ, unspecified	0.002	0.998	0.000
D01.7 Other specified digestive organs	0.002	0.998	0.000
D01.4 Other and unspecified parts of intestine	0.002	0.998	0.000
D01.1 Rectosigmoid junction	0.002	0.998	0.000
M94.07 Chondrocostal junction syndrome [Tietze]-Ankle/foot	0.000	0.998	0.002
M94.06 Chondrocostal junction syndrome [Tietze]-Lower leg	0.000	0.998	0.002
M94.05 Chondrocostal junction syndrome [Tietze]-Pelvic/thigh	0.000	0.998	0.002
M94.04 Chondrocostal junction syndrome [Tietze]-Hand	0.000	0.998	0.002
M94.03 Chondrocostal junction syndrome [Tietze]-Forearm	0.000	0.998	0.002
M94.02 Chondrocostal junction syndrome [Tietze]-Upper arm	0.000	0.998	0.002
M94.01 Chondrocostal junction syndrome [Tietze]-Shldr region	0.000	0.998	0.002
M94.00 Chondrocostal junction syndrome [Tietze]-Mult sites	0.000	0.998	0.002
D00.2 Stomach	0.002	0.998	0.000
D01.5 Liver, gallbladder and bile ducts	0.002	0.998	0.000
D03.6 Melanoma in situ of upper limb, including shoulder	0.002	0.998	0.000
D09.3 Thyroid and other endocrine glands	0.002	0.998	0.000
D09.2 Eye	0.002	0.998	0.000
D68.5 Primary Thrombophilia	0.000	0.998	0.002
J11.1 Influenza with other respiratory manifestations, virus not identified	0.000	0.998	0.002
C16.9 Stomach, unspecified	0.002	0.998	0.000
T66-T78 Other and unspecified effects of external causes	0.002	0.998	0.000
M94.09 Chondrocostal junction syndrome [Tietze]-Site unspec	0.000	0.998	0.002
D01.0 Colon	0.002	0.998	0.000
K63.4 Enteroptosis	0.002	0.998	0.000
M94.19 Relapsing polychondritis (Site unspecified)	0.000	0.998	0.002
M94.18 Relapsing polychondritis (Other)	0.000	0.998	0.002
M94.17 Relapsing polychondritis (Ankle and foot)	0.000	0.998	0.002
M94.16 Relapsing polychondritis (Lower leg)	0.000	0.998	0.002
M94.15 Relapsing polychondritis (Pelvic region and thigh)	0.000	0.998	0.002
M94.14 Relapsing polychondritis (Hand)	0.000	0.998	0.002
M94.13 Relapsing polychondritis (Forearm)	0.000	0.998	0.002
M94.12 Relapsing polychondritis (Upper arm)	0.000	0.998	0.002
M94.11 Relapsing polychondritis (Shoulder region)	0.000	0.998	0.002
M94.10 Relapsing polychondritis (Multiple sites)	0.000	0.998	0.002
M94.39 Chondrolysis (Site unspecified)	0.000	0.998	0.002
M94.38 Chondrolysis (Other)	0.000	0.998	0.002
M94.37 Chondrolysis (Ankle and foot)	0.000	0.998	0.002
M94.36 Chondrolysis (Lower leg)	0.000	0.998	0.002
M94.35 Chondrolysis (Pelvic region and thigh)	0.000	0.998	0.002
M94.34 Chondrolysis (Hand)	0.000	0.998	0.002
M94.33 Chondrolysis (Forearm)	0.000	0.998	0.002
M94.32 Chondrolysis (Upper arm)	0.000	0.998	0.002
M94.31 Chondrolysis (Shoulder region)	0.000	0.998	0.002
M94.30 Chondrolysis (Multiple sites)	0.000	0.998	0.002
D00.1 Oesophagus	0.002	0.998	0.000
D01.3 Anus and anal canal	0.002	0.998	0.000
D09.1 Other and unspecified urinary organs	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations